Alnylam Pharmaceuticals, Inc. (ALNY) is around the top of the Biotechnology industry according to InvestorsObserver. ALNY received an overall rating of 65, which means that it scores higher than 65 percent of all stocks. Alnylam Pharmaceuticals, Inc. also achieved a score of 81 in the Biotechnology industry, putting it above 81 percent of Biotechnology stocks. Biotechnology is ranked 57 out of the 148 industries.
ALNY has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on ALNY!